Sigma Square Capital

Sigma Square Capital is a growth equity and venture capital firm established in 2015 and based in Beijing, China. The firm specializes in investing in high-growth emerging industries, focusing on sectors such as technology, media, and telecommunications (TMT), healthcare, and consumption upgrades. With a commitment to identifying and supporting innovative companies, Sigma Square Capital aims to facilitate growth and development in dynamic markets.

Peter Zhang

Founder

14 past transactions

ABclonal

Series C in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Waytous

Series A in 2020
Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction industries. Founded in November 2014, Waytous develops a cloud-based system that integrates unmanned driving for mining trucks and collaborative operation management for excavators. The company emphasizes the creation of a comprehensive training data and research and development ecosystem to enhance the performance and quality of its intelligent vehicles. Through its innovative technology, Waytous aims to improve operational efficiency and safety in heavy-duty applications.

VIPioneers

Series A in 2020
Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

VIPioneers

Series A in 2019
Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

GenomePrecision

Series B in 2019
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.

Iris Integrated Retail Information Solution

Series B in 2018
Iris Integrated Retail Information Solution is a retail IT solution provider based in Shanghai, China. The company specializes in offering a range of enterprise services that include IT retail data operations, business intelligence solutions, and cloud-based management systems. Iris provides the Iris BI 1.2 Pro series, an integrated application designed for businesses engaged in retail data processing across various industries. Additionally, the company develops mobile applications and offers services in mobile IT products, including eBook production and app development. Iris also provides IT consulting and training services to support businesses in optimizing their operations and leveraging technology effectively.

Fanlai Tech

Series B in 2018
Shenzhen Fanlai Technology Co., Ltd. specializes in developing innovative kitchen automation solutions and smart kitchen appliances. Based in Shenzhen, China, the company focuses on integrating intelligent automation and artificial intelligence into its products, allowing consumers to prepare homemade meals with greater ease and efficiency. By combining advanced technology with user-friendly design, Fanlai Tech aims to enhance the cooking experience in households.

Liking Fit

Series C in 2018
Liking Fit is a Chinese franchise smart gym operator, established in September 2014 and headquartered in Shanghai. The company specializes in the development and operation of 24-hour intelligent gyms, utilizing an online platform that allows users to access facilities via a mobile app or smartwatches. This innovative approach enables members to engage in fitness activities at their convenience while also monitoring their health data on the cloud. Liking Fit supports its franchisees by providing a comprehensive range of services, including gym outfitting, smart technical assistance, training, promotion, and post-management. The franchise model allows for a unique unmanned management system, where franchisees can oversee operations through mobile devices. Currently, Liking Fit has formed strategic partnerships with notable real estate companies and has established over 100 franchise locations worldwide.

No Panda Culture (Bukongwenhua)

Series A in 2017
No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Withwheat

Series B in 2017
Withwheat is a bakery chain that focuses on producing high-quality European-style soft bread and a variety of baked goods, including pastries and fruit cakes. The brand is known for its commitment to health-conscious baking, utilizing significantly lower amounts of sugar and oil compared to traditional bread, and avoiding preservatives, trans fats, and artificial flavors. This emphasis on quality and health has resulted in strong consumer demand. Withwheat operates micro shops throughout Beijing, allowing for efficient distribution of its products to a wide audience.

DeePhi

Series A in 2017
DeePhi Technology Co., Ltd. is a Beijing-based company specializing in deep learning artificial intelligence computing applications. Founded in 2016, it develops solutions that integrate deep compression and a dedicated processing unit (DPU) to optimize performance across a range of devices, from large servers to mobile terminals. The company focuses on improving neural network efficiency through techniques such as compression, pruning, and system-level optimization, facilitating low-power and low-latency AI services. DeePhi's technology is utilized in various sectors, including drone technology, security surveillance, and cloud services. By offering end-to-end solutions, DeePhi aims to enhance the effectiveness and economy of AI inference platforms for both embedded systems and server-side applications. The company operates as a subsidiary of Xilinx, Inc.

Manman app

Series A in 2017
Manman is a mobile comics platform established in Beijing in 2017, specializing in the production and distribution of original comic content. With over 980 titles available, including 315 exclusives, the app has cultivated a user base exceeding 14 million, of which 3 million are active users. Notably, 2 million users maintain more than 20 subscriptions, demonstrating a strong engagement with the platform. Manman aims to generate revenue through paid subscriptions, advertising, and reward systems, enhancing the entertainment experience for its audience by providing diverse and novel comic topics.

GenomePrecision

Series A in 2017
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.

Novogene

Series B in 2016
Novogene Co., Ltd. is a prominent global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Founded in 2011 and headquartered in Beijing, China, the company operates with a large workforce and boasts the highest sequencing capacity worldwide. Novogene offers a wide range of genomic solutions, including human genome sequencing, cancer genomic profiling, and various applications for animals, plants, and microbes. Their advanced services also encompass clinical-grade whole exome sequencing and specialized diagnostic assays for cancer therapies. The company is recognized for its commitment to data quality and customer service, having produced over 1850 research papers in prestigious journals. Dr. Ruiqiang Li, the founder and a leading expert in genomics, has significantly contributed to the field through multiple patents and influential publications, fostering Novogene's reputation as a leader in the genomics sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.